Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C090937 |
3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole |
3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole results in increased expression of PRKG1 protein | increases expression | 11602670
|
C439285 |
(5-fluoro-2-methyl-1-(4-pyridyl)methylene-3-(N-benzyl)-indene)-acetamide hydrochloride |
(5-fluoro-2-methyl-1-(4-pyridyl)methylene-3-(N-benzyl)-indene)-acetamide hydrochloride results in increased expression of PRKG1 protein | increases expression | 11602670
|
C055656 |
8-((4-chlorophenyl)thio)cyclic-3',5'-GMP |
[8-((4-chlorophenyl)thio)cyclic-3',5'-GMP co-treated with PRKG1 protein alternative form] inhibits the reaction [Phenylephrine results in increased expression of NPPA mRNA] | affects cotreatment|decreases reaction|increases expression | 11799084
|
C055656 |
8-((4-chlorophenyl)thio)cyclic-3',5'-GMP |
8-((4-chlorophenyl)thio)cyclic-3',5'-GMP results in decreased expression of PRKG1 protein alternative form | decreases expression | 11799084
|
C055656 |
8-((4-chlorophenyl)thio)cyclic-3',5'-GMP |
8-((4-chlorophenyl)thio)cyclic-3',5'-GMP results in increased activity of PRKG1 protein | increases activity | 11799084
|
C090860 |
8-(4-chlorophenylthio)guanosine 3',5'-cyclic monophosphorothioate |
8-(4-chlorophenylthio)guanosine 3',5'-cyclic monophosphorothioate binds to and results in decreased activity of PRKG1 protein | affects binding|decreases activity | 19542178
|
C016276 |
8-bromocyclic GMP |
8-bromocyclic GMP results in increased activity of PRKG1 protein | increases activity | 19359370
|
C056165 |
acetovanillone |
acetovanillone inhibits the reaction [Glucose results in decreased expression of PRKG1 protein] | decreases expression|decreases reaction | 17320767
|
D000641 |
Ammonia |
PRKG1 protein affects the susceptibility to Ammonia | affects response to substance | 19393034
|
C015001 |
arsenite |
[arsenite co-treated with Benzo(a)pyrene] results in decreased expression of PRKG1 mRNA | affects cotreatment|decreases expression | 15894712
|
C015001 |
arsenite |
arsenite results in decreased expression of PRKG1 mRNA | decreases expression | 15894712
|
D001564 |
Benzo(a)pyrene |
[arsenite co-treated with Benzo(a)pyrene] results in decreased expression of PRKG1 mRNA | affects cotreatment|decreases expression | 15894712
|
D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in decreased expression of PRKG1 mRNA | decreases expression | 15894712
|
D015123 |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of PRKG1 mRNA | decreases expression | 20382639
|
D002251 |
Carbon Tetrachloride |
Carbon Tetrachloride affects the expression of PRKG1 mRNA | affects expression | 17484886
|
D016572 |
Cyclosporine |
Cyclosporine results in increased expression of PRKG1 mRNA | increases expression | 16378109
|
D016572 |
Cyclosporine |
Cyclosporine results in increased expression of PRKG1 protein | increases expression | 16378109
|
D016572 |
Cyclosporine |
Phenylephrine inhibits the reaction [Cyclosporine results in increased expression of PRKG1 mRNA] | decreases reaction|increases expression | 16378109
|
D016572 |
Cyclosporine |
Phenylephrine inhibits the reaction [Cyclosporine results in increased expression of PRKG1 protein] | decreases reaction|increases expression | 16378109
|
D004041 |
Dietary Fats |
Dietary Fats results in increased expression of PRKG1 mRNA | increases expression | 18042831
|
C007517 |
diphenyleneiodonium |
diphenyleneiodonium inhibits the reaction [Glucose results in decreased expression of PRKG1 protein] | decreases expression|decreases reaction | 17320767
|
D004610 |
Ellagic Acid |
Ellagic Acid results in decreased expression of PRKG1 mRNA | decreases expression | 12002526
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol affects the expression of PRKG1 mRNA | affects expression | 17555576
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol results in decreased expression of PRKG1 mRNA | decreases expression | 17942748
|
D005947 |
Glucose |
acetovanillone inhibits the reaction [Glucose results in decreased expression of PRKG1 protein] | decreases expression|decreases reaction | 17320767
|
D005947 |
Glucose |
diphenyleneiodonium inhibits the reaction [Glucose results in decreased expression of PRKG1 protein] | decreases expression|decreases reaction | 17320767
|
D005947 |
Glucose |
Glucose results in decreased expression of and results in decreased activity of PRKG1 protein | decreases activity|decreases expression | 17320767
|
D005947 |
Glucose |
Glucose results in decreased expression of PRKG1 mRNA | decreases expression | 17320767
|
D005947 |
Glucose |
manganese(III)-tetrakis(4-benzoic acid)porphyrin inhibits the reaction [Glucose results in decreased expression of PRKG1 protein] | decreases expression|decreases reaction | 17320767
|
D005947 |
Glucose |
Reactive Oxygen Species promotes the reaction [Glucose results in decreased expression of PRKG1 protein] | decreases expression|increases reaction | 17320767
|
D005947 |
Glucose |
tempol inhibits the reaction [Glucose results in decreased expression of PRKG1 protein] | decreases expression|decreases reaction | 17320767
|
D006152 |
Cyclic GMP |
Cyclic GMP results in increased activity of PRKG1 protein | increases activity | 18037907
|
D006830 |
Hydralazine |
[Hydralazine co-treated with Valproic Acid] results in increased expression of PRKG1 mRNA | affects cotreatment|increases expression | 17183730
|
C097284 |
manganese(III)-tetrakis(4-benzoic acid)porphyrin |
manganese(III)-tetrakis(4-benzoic acid)porphyrin inhibits the reaction [Glucose results in decreased expression of PRKG1 protein] | decreases expression|decreases reaction | 17320767
|
D005996 |
Nitroglycerin |
Nitroglycerin results in decreased expression of PRKG1 protein | decreases expression | 11331261
|
D005996 |
Nitroglycerin |
Nitroglycerin results in decreased expression of PRKG1 protein | decreases expression | 11331261
|
D005996 |
Nitroglycerin |
Nitroglycerin affects the expression of PRKG1 mRNA | affects expression | 18037907
|
D005996 |
Nitroglycerin |
Nitroglycerin affects the expression of PRKG1 protein | affects expression | 18037907
|
D005996 |
Nitroglycerin |
Nitroglycerin results in increased activity of PRKG1 protein | increases activity | 18037907
|
D005996 |
Nitroglycerin |
Superoxides affects the reaction [Nitroglycerin results in increased activity of PRKG1 protein] | affects reaction|increases activity | 18037907
|
D026423 |
S-Nitroso-N-Acetylpenicillamine |
[S-Nitroso-N-Acetylpenicillamine co-treated with PRKG1 protein alternative form] inhibits the reaction [Phenylephrine results in increased expression of NPPA mRNA] | affects cotreatment|decreases reaction|increases expression | 11799084
|
D026423 |
S-Nitroso-N-Acetylpenicillamine |
S-Nitroso-N-Acetylpenicillamine results in increased activity of PRKG1 protein | increases activity | 11799084
|
C041786 |
palm oil |
palm oil results in increased expression of PRKG1 mRNA | increases expression | 18042831
|
D010656 |
Phenylephrine |
[8-((4-chlorophenyl)thio)cyclic-3',5'-GMP co-treated with PRKG1 protein alternative form] inhibits the reaction [Phenylephrine results in increased expression of NPPA mRNA] | affects cotreatment|decreases reaction|increases expression | 11799084
|
D010656 |
Phenylephrine |
FLT1 protein promotes the reaction [Phenylephrine results in increased activity of PRKG1 protein] | increases activity|increases reaction | 19542178
|
D010656 |
Phenylephrine |
PDE1A protein promotes the reaction [Phenylephrine results in decreased activity of PRKG1 protein] | decreases activity|increases reaction | 19797176
|
D010656 |
Phenylephrine |
Phenylephrine inhibits the reaction [Cyclosporine results in increased expression of PRKG1 mRNA] | decreases reaction|increases expression | 16378109
|
D010656 |
Phenylephrine |
Phenylephrine inhibits the reaction [Cyclosporine results in increased expression of PRKG1 protein] | decreases reaction|increases expression | 16378109
|
D010656 |
Phenylephrine |
Phenylephrine results in decreased activity of PRKG1 protein | decreases activity | 19797176
|
D010656 |
Phenylephrine |
Phenylephrine results in increased activity of PRKG1 protein | increases activity | 19542178
|
D010656 |
Phenylephrine |
[S-Nitroso-N-Acetylpenicillamine co-treated with PRKG1 protein alternative form] inhibits the reaction [Phenylephrine results in increased expression of NPPA mRNA] | affects cotreatment|decreases reaction|increases expression | 11799084
|
C006253 |
pirinixic acid |
[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of PRKG1 mRNA | affects binding|decreases expression|increases activity | 19710929
|
D017382 |
Reactive Oxygen Species |
Reactive Oxygen Species promotes the reaction [Glucose results in decreased expression of PRKG1 protein] | decreases expression|increases reaction | 17320767
|
D013395 |
Sucrose |
Sucrose results in decreased expression of PRKG1 protein | decreases expression | 17215582
|
C025463 |
sulindac sulfone |
sulindac sulfone results in increased expression of PRKG1 protein | increases expression | 11602670 16731751
|
D013481 |
Superoxides |
Superoxides affects the reaction [Nitroglycerin results in increased activity of PRKG1 protein] | affects reaction|increases activity | 18037907
|
D013629 |
Tamoxifen |
Tamoxifen affects the expression of PRKG1 mRNA | affects expression | 17555576
|
C001803 |
tempol |
tempol inhibits the reaction [Glucose results in decreased expression of PRKG1 protein] | decreases expression|decreases reaction | 17320767
|
C004648 |
testosterone enanthate |
testosterone enanthate affects the expression of PRKG1 mRNA | affects expression | 17440010
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of PRKG1 mRNA | increases expression | 20159946
|
D014635 |
Valproic Acid |
[Hydralazine co-treated with Valproic Acid] results in increased expression of PRKG1 mRNA | affects cotreatment|increases expression | 17183730
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000008 |
Abdominal Neoplasms |
|
Tamoxifen |
4.20 | 14745880 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
7.19 | 11752688 14514962 15322242 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Valproic Acid |
7.19 | 8875741 |
MESH:D000015 |
Abnormalities, Multiple |
|
Valproic Acid |
3.62 | 19490988 |
MESH:D000152 |
Acne Vulgaris |
|
Ethinyl Estradiol |
3.60 | 17505938 |
MESH:D058186 |
Acute Kidney Injury |
|
Superoxides |
4.80 | 18460982 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
2.81 | 18653653 |
MESH:D000230 |
Adenocarcinoma |
|
Benzo(a)pyrene |
3.87 | 20464547 20127859 |
MESH:D000230 |
Adenocarcinoma |
|
Ethinyl Estradiol |
3.87 | 14692618 |
MESH:D000236 |
Adenoma |
|
Benzo(a)pyrene |
2.46 | 6695378 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
8.77 | 16434500 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
8.77 | 16835633 |
MESH:D011125 |
Adenomatous Polyposis Coli |
|
sulindac sulfone |
5.00 | 16150858 |
MESH:D000550 |
Amblyopia |
|
Valproic Acid |
4.89 | 17688650 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
2.65 | 11748828 |
MESH:D000756 |
Anemia, Sideroblastic |
|
Superoxides |
5.32 | 16910769 |
MESH:D001008 |
Anxiety Disorders |
|
Valproic Acid |
3.31 | 17497229 |
MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Benzo(a)pyrene |
3.74 | 19183758 |
MESH:D001145 |
Arrhythmias, Cardiac |
|
Phenylephrine |
3.82 | 17460149 |
MESH:D001161 |
Arteriosclerosis |
|
Dietary Fats |
8.80 | 15238619 |
MESH:D001161 |
Arteriosclerosis |
|
Ethinyl Estradiol |
8.80 | 11256880 |
MESH:D001169 |
Arthritis, Experimental |
|
Ethinyl Estradiol |
2.45 | 15885639 |
MESH:D001321 |
Autistic Disorder |
|
Valproic Acid |
2.04 | 19460635 20603192 18396377 15238991 18316065 17507914 18177632 18940202 17688650 18985861 19232924 18558336 17157402 18775368 16609825 |
MESH:D001714 |
Bipolar Disorder |
|
Valproic Acid |
2.90 | 20046352 17594078 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
7.76 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
7.76 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.44 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
7.30 | 15746008 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Valproic Acid |
7.30 | 8888407 |
MESH:D001919 |
Bradycardia |
|
Phenylephrine |
4.20 | 15306635 |
MESH:D001929 |
Brain Edema |
|
Ammonia |
5.93 | 11481608 20217200 19393034 |
MESH:D001943 |
Breast Neoplasms |
|
Benzo(a)pyrene |
1.87 | 20146248 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
Dietary Fats |
1.87 | 20435547 |
MESH:D001943 |
Breast Neoplasms |
|
Tamoxifen |
1.87 | 19189210 20135344 16873071 19059307 19084267 16273361 19142967 20005174 17440819 19066611 15668708 19103187 19189212 19200415 16202921 21138602 19011961 21152245 15565566 17261762 17893378 19244106 18815881 20065188 19115204 16818667 19221464 11161223 20859285 20390343 18855134 18997820 18351453 19288272 20544844 19487384 18821012 17242785 18425577 18629630 19289846 18984771 19155303 17049068 19410462 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
1.87 | 20435547 |
MESH:D002252 |
Carbon Tetrachloride Poisoning |
|
Carbon Tetrachloride |
3.45 | 10355542 16050911 18705752 15700767 16097048 15721981 16011737 15673190 3786805 16192424 16124888 16227642 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.53 | 16835633 |
MESH:D018270 |
Carcinoma, Ductal, Breast |
|
Tamoxifen |
4.17 | 19066611 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Carbon Tetrachloride |
2.83 | 18788625 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tamoxifen |
2.83 | 16924424 |
MESH:D002289 |
Carcinoma, Non-Small-Cell Lung |
|
sulindac sulfone |
3.96 | 18758305 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Benzo(a)pyrene |
1.95 | 20419170 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Tamoxifen |
3.32 | 17572228 |
MESH:D006332 |
Cardiomegaly |
|
Phenylephrine |
6.25 | 17124262 11179087 15728586 11754973 17287366 16170337 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
6.25 | 16120746 18670907 18850075 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
5.78 | 20889678 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
5.78 | 12371664 |
MESH:D002659 |
Child Development Disorders, Pervasive |
|
Valproic Acid |
2.58 | 20734317 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
2.88 | 16835633 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
11.89 | 19486331 |
MESH:D002779 |
Cholestasis |
|
Ethinyl Estradiol |
11.89 | 16919318 15861022 16105132 17333356 17681005 17110522 11677210 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
11.89 | 19176532 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
1.96 | 8697196 15668235 16354765 12621046 15340226 |
MESH:D003110 |
Colonic Neoplasms |
|
arsenite |
2.53 | 15037631 |
MESH:D015179 |
Colorectal Neoplasms |
|
sulindac sulfone |
3.37 | 10666051 18059344 10416599 11197048 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
2.78 | 14669216 17141729 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Reactive Oxygen Species |
3.69 | 15736158 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
3.69 | 15322242 10048152 20055451 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Valproic Acid |
3.69 | 8888407 16575769 17688650 |
MESH:D003711 |
Demyelinating Diseases |
|
Tamoxifen |
4.03 | 19031437 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
Ammonia |
4.44 | 16823706 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.27 | 18249437 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.58 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
Tamoxifen |
3.19 | 19279558 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Carbon Tetrachloride |
5.57 | 6884620 19085960 19336974 2869522 21278145 9327722 15027814 11566570 10915739 15968718 10092053 6623471 7179309 15998439 3786805 4309450 7120509 17522070 3732212 7440962 16177239 16227642 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
5.57 | 20420201 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Valproic Acid |
5.57 | 1733752 19641884 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.51 | 11462148 |
MESH:D050171 |
Dyslipidemias |
|
Dietary Fats |
3.21 | 18367378 |
MESH:D004421 |
Dystonia |
|
Valproic Acid |
3.74 | 1851702 |
MESH:D004487 |
Edema |
|
pirinixic acid |
5.55 | 12083418 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
5.55 | 11000095 12711302 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
3.56 | 18230668 16714409 15322242 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Ethinyl Estradiol |
7.87 | 12538720 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Tamoxifen |
7.87 | 19031437 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tamoxifen |
2.82 | 20544844 16202921 19155303 17893378 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
2.73 | 10568697 9294722 |
MESH:D004831 |
Epilepsies, Myoclonic |
|
Valproic Acid |
3.82 | 3659116 17275665 |
MESH:D004828 |
Epilepsies, Partial |
|
Valproic Acid |
3.57 | 16628512 3922381 |
MESH:D004827 |
Epilepsy |
|
Valproic Acid |
2.76 | 20417680 18234410 |
MESH:D004832 |
Epilepsy, Absence |
|
Valproic Acid |
3.31 | 6426943 6254150 7562514 |
MESH:D017029 |
Epilepsy, Complex Partial |
|
Valproic Acid |
3.96 | 7750514 |
MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Valproic Acid |
3.72 | 3659116 |
MESH:D004938 |
Esophageal Neoplasms |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
4.03 | 20426865 |
MESH:D004938 |
Esophageal Neoplasms |
|
Benzo(a)pyrene |
4.03 | 16530937 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
2.76 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
arsenite |
38.03 | 18296743 |
MESH:D005234 |
Fatty Liver |
|
Carbon Tetrachloride |
38.03 | 15959796 61145 12631006 19224547 16239168 17595544 16045604 12795759 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
38.03 | 19224547 |
MESH:D005234 |
Fatty Liver |
|
Dietary Fats |
38.03 | 19551842 19004024 17967931 18296743 |
MESH:D005234 |
Fatty Liver |
|
Ethinyl Estradiol |
38.03 | 15345470 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
38.03 | 19236843 20131406 |
MESH:D005234 |
Fatty Liver |
|
Tamoxifen |
38.03 | 14986274 19224547 |
MESH:D005234 |
Fatty Liver |
|
Valproic Acid |
38.03 | 14986274 19224547 |
MESH:D052776 |
Female Urogenital Diseases |
|
Tamoxifen |
3.03 | 16709447 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.12 | 11858732 |
MESH:D005315 |
Fetal Diseases |
|
Valproic Acid |
4.54 | 16575769 |
MESH:D005317 |
Fetal Growth Retardation |
|
Valproic Acid |
3.81 | 8888407 18558336 |
MESH:D018221 |
Fibromatosis, Abdominal |
|
Tamoxifen |
4.19 | 14745880 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Tamoxifen |
3.84 | 19069698 |
MESH:D005355 |
Fibrosis |
|
arsenite |
24.20 | 18296743 |
MESH:D005355 |
Fibrosis |
|
Carbon Tetrachloride |
24.20 | 18705752 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
24.20 | 12168785 12639820 |
MESH:D005355 |
Fibrosis |
|
Dietary Fats |
24.20 | 18296743 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
24.20 | 20067830 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
3.88 | 8708960 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.25 | 10696789 |
MESH:D006261 |
Headache |
|
Nitroglycerin |
4.84 | 11284996 11554966 |
MESH:D006330 |
Heart Defects, Congenital |
|
Benzo(a)pyrene |
5.84 | 20471113 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
5.84 | 11294989 10048152 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
2.33 | 20558911 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.08 | 15720958 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.03 | 11000095 |
MESH:D006501 |
Hepatic Encephalopathy |
|
Ammonia |
5.51 | 12420312 16338762 20549931 |
MESH:D006505 |
Hepatitis |
|
Carbon Tetrachloride |
3.27 | 19110552 19900420 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
7.16 | 19772884 16221962 18467677 19176532 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
7.16 | 16120746 12621046 15340226 |
MESH:D019247 |
HIV Wasting Syndrome |
|
testosterone enanthate |
5.40 | 17440010 |
MESH:D006849 |
Hydrocephalus |
|
Valproic Acid |
4.53 | 17688650 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
3.70 | 15340226 16354765 8697196 18606429 16959395 |
MESH:D006932 |
Hyperbilirubinemia |
|
Carbon Tetrachloride |
4.19 | 16899240 |
MESH:D006937 |
Hypercholesterolemia |
|
Dietary Fats |
3.29 | 21332399 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
2.89 | 20558911 |
MESH:D020138 |
Hyperhomocysteinemia |
|
Superoxides |
4.98 | 12615666 |
MESH:D006949 |
Hyperlipidemias |
|
Dietary Fats |
3.30 | 21332399 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
7.82 | 10903974 |
MESH:D006973 |
Hypertension |
|
Phenylephrine |
7.82 | 12717712 8949925 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
7.82 | 18670907 18850075 |
MESH:D006975 |
Hypertension, Portal |
|
Carbon Tetrachloride |
3.75 | 15338365 |
MESH:D046110 |
Hypertension, Pregnancy-Induced |
|
Hydralazine |
4.29 | 16612254 |
MESH:D006984 |
Hypertrophy |
|
Phenylephrine |
4.25 | 12791704 18502941 |
MESH:D007021 |
Hypospadias |
|
Ethinyl Estradiol |
3.48 | 16945680 16569931 |
MESH:D007247 |
Infertility, Female |
|
Ethinyl Estradiol |
3.15 | 12013081 |
MESH:D007248 |
Infertility, Male |
|
Ethinyl Estradiol |
2.26 | 17937319 |
MESH:D007249 |
Inflammation |
|
Dietary Fats |
7.23 | 20412841 |
MESH:D007249 |
Inflammation |
|
Tamoxifen |
7.23 | 19457130 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
7.23 | 12200463 12878042 |
MESH:D007333 |
Insulin Resistance |
|
Dietary Fats |
6.51 | 18457598 11836018 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
6.51 | 16306350 |
MESH:D007410 |
Intestinal Diseases |
|
Superoxides |
5.11 | 10210152 |
MESH:D002532 |
Intracranial Aneurysm |
|
Reactive Oxygen Species |
4.68 | 19381132 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.03 | 16580747 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
4.09 | 15604871 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
6.07 | 18776723 8314463 10903974 |
MESH:D007674 |
Kidney Diseases |
|
tempol |
6.07 | 17640563 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
6.39 | 12371664 |
MESH:D007680 |
Kidney Neoplasms |
|
Tamoxifen |
6.39 | 18625569 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Valproic Acid |
2.09 | 16294345 17596541 |
MESH:D008064 |
Lipidoses |
|
Tamoxifen |
2.91 | 17567588 15342952 |
MESH:D008103 |
Liver Cirrhosis |
|
arsenite |
9.99 | 18296743 |
MESH:D008103 |
Liver Cirrhosis |
|
Carbon Tetrachloride |
9.99 | 17334410 16943688 21278145 16221502 11408273 11903743 17174718 16239168 17157831 |
MESH:D008103 |
Liver Cirrhosis |
|
Dietary Fats |
9.99 | 18296743 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Carbon Tetrachloride |
4.54 | 18054572 15057751 15052691 17565644 18412020 15362042 17698563 15730626 16638106 15893842 12389079 11481614 12649538 15123356 18006644 17721639 17823541 18429990 14620537 17766677 18420326 12667390 15925388 18705752 18251166 18166357 16011737 15338365 18472332 16116963 12609069 18279442 18277467 15996030 14748882 12958196 16097048 14716833 15959796 15673190 14716496 18481824 16033810 16248980 14512876 12632514 12666154 10355542 17976157 18418968 12898905 18187930 17922224 17631135 15370692 20821823 17708605 17805973 17900296 16192424 12445418 17640975 17714472 18205269 15931870 14724832 16136751 12586293 18472094 15876570 18376398 12445421 16015684 18317297 17481882 18339082 18395095 16027843 12546737 17525996 18395914 18210741 17761835 18156304 15818738 13678700 17557913 17944888 17869086 18263696 12741479 12632512 15650968 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
4.54 | 15474484 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tamoxifen |
4.54 | 18564211 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
4.54 | 12878042 |
MESH:D008107 |
Liver Diseases |
|
Carbon Tetrachloride |
2.00 | 15830285 17285989 16964402 15720792 16246199 |
MESH:D017093 |
Liver Failure |
|
Carbon Tetrachloride |
3.83 | 15123358 |
MESH:D017114 |
Liver Failure, Acute |
|
Carbon Tetrachloride |
3.40 | 14706259 16899240 |
MESH:D008113 |
Liver Neoplasms |
|
Benzo(a)pyrene |
12.77 | 21137059 20195826 |
MESH:D008113 |
Liver Neoplasms |
|
Carbon Tetrachloride |
12.77 | 19294768 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
12.77 | 15890375 20007298 16377806 |
MESH:D008113 |
Liver Neoplasms |
|
Tamoxifen |
12.77 | 16684651 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
12.77 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Carbon Tetrachloride |
5.06 | 15583823 12014681 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
5.06 | 12151625 |
MESH:D017563 |
Lung Diseases, Interstitial |
|
Valproic Acid |
3.92 | 17228818 |
MESH:D008175 |
Lung Neoplasms |
|
arsenite |
4.48 | 16809336 |
MESH:D008175 |
Lung Neoplasms |
|
Benzo(a)pyrene |
4.48 | 20135361 17053015 18816296 18520028 18569708 20064080 20464547 20869020 6695378 |
MESH:D008175 |
Lung Neoplasms |
|
Tamoxifen |
4.48 | 18625569 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
4.48 | 19555203 11884234 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
Tamoxifen |
3.42 | 19428831 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Tamoxifen |
2.41 | 11731420 16827153 14580682 19196723 19196722 |
MESH:D020149 |
Manganese Poisoning |
|
Tamoxifen |
4.20 | 19453300 |
MESH:D008545 |
Melanoma |
|
8-bromocyclic GMP |
6.96 | 18004088 |
MESH:D008545 |
Melanoma |
|
Glucose |
6.96 | 14993021 |
MESH:D008545 |
Melanoma |
|
Reactive Oxygen Species |
6.96 | 17992120 |
MESH:D008545 |
Melanoma |
|
Tamoxifen |
6.96 | 12393984 19393235 |
MESH:D018328 |
Melanoma, Amelanotic |
|
Tamoxifen |
3.84 | 15990972 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
4.44 | 16801185 |
MESH:D008708 |
Methemoglobinemia |
|
Nitroglycerin |
4.42 | 3537620 |
MESH:D008881 |
Migraine Disorders |
|
Valproic Acid |
2.95 | 18765137 18803445 |
MESH:D020326 |
Migraine without Aura |
|
Cyclic GMP |
10.40 | 11304026 |
MESH:D020326 |
Migraine without Aura |
|
Nitroglycerin |
10.40 | 14659530 |
MESH:D009062 |
Mouth Neoplasms |
|
Benzo(a)pyrene |
2.93 | 16381670 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.17 | 16239165 |
MESH:D009139 |
Musculoskeletal Abnormalities |
|
Valproic Acid |
3.72 | 8888407 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Valproic Acid |
2.96 | 17596541 |
MESH:D009203 |
Myocardial Infarction |
|
Nitroglycerin |
5.53 | 14729435 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
5.53 | 19151258 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
2.75 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
2.69 | 16411023 |
MESH:D009362 |
Neoplasm Metastasis |
|
Tamoxifen |
2.41 | 19393235 |
MESH:D009364 |
Neoplasm Recurrence, Local |
|
Tamoxifen |
2.40 | 19410462 |
MESH:D009369 |
Neoplasms |
|
Benzo(a)pyrene |
4.25 | 11141357 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
4.25 | 17405874 |
MESH:D009376 |
Neoplasms, Hormone-Dependent |
|
Tamoxifen |
3.65 | 19200415 19189210 19196722 |
MESH:D009389 |
Neovascularization, Pathologic |
|
arsenite |
4.07 | 15738583 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
4.09 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
3.00 | 18481113 19348381 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
2.89 | 14600291 |
MESH:D009436 |
Neural Tube Defects |
|
Valproic Acid |
2.91 | 8888407 16359493 |
MESH:D009765 |
Obesity |
|
Dietary Fats |
4.13 | 20132043 21332399 17217161 18674790 18457598 11836018 20518802 19632207 16723640 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
4.13 | 20558911 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Reactive Oxygen Species |
3.57 | 15580305 |
MESH:D016584 |
Panic Disorder |
|
Ethinyl Estradiol |
3.37 | 11578682 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
3.90 | 12520081 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.24 | 18163543 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
2.94 | 12371664 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
8.33 | 11118676 11399792 11222880 11896295 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Valproic Acid |
8.33 | 20603192 |
MESH:D011471 |
Prostatic Neoplasms |
|
Benzo(a)pyrene |
2.84 | 17292933 |
MESH:D011471 |
Prostatic Neoplasms |
|
sulindac sulfone |
2.84 | 15570007 17908994 |
MESH:D011471 |
Prostatic Neoplasms |
|
Tamoxifen |
2.84 | 15067354 |
MESH:D011537 |
Pruritus |
|
Ethinyl Estradiol |
2.98 | 16919318 15861022 |
MESH:D019310 |
Pseudolymphoma |
|
Valproic Acid |
4.19 | 11422049 12752131 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.11 | 16882103 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
6.46 | 19058328 |
MESH:D015427 |
Reperfusion Injury |
|
Superoxides |
6.46 | 18460982 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.51 | 18990726 |
MESH:D012174 |
Retinitis Pigmentosa |
|
manganese(III)-tetrakis(4-benzoic acid)porphyrin |
4.51 | 16849425 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Valproic Acid |
3.86 | 19155313 |
MESH:D012559 |
Schizophrenia |
|
Valproic Acid |
2.02 | 19110320 15737665 |
MESH:D012640 |
Seizures |
|
Valproic Acid |
2.52 | 14763951 17978042 11044598 1511512 3137016 16876388 11738929 15475178 |
MESH:D012852 |
Sinusitis |
|
Phenylephrine |
4.36 | 7327846 |
MESH:D012878 |
Skin Neoplasms |
|
8-bromocyclic GMP |
12.36 | 18004088 |
MESH:D012878 |
Skin Neoplasms |
|
Benzo(a)pyrene |
12.36 | 19755658 10029692 |
MESH:D012878 |
Skin Neoplasms |
|
Glucose |
12.36 | 14993021 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
12.36 | 16192470 |
MESH:D013088 |
Spermatocele |
|
Ethinyl Estradiol |
10.41 | 16709447 |
MESH:D013088 |
Spermatocele |
|
Tamoxifen |
10.41 | 16709447 |
MESH:D013119 |
Spinal Cord Injuries |
|
Tamoxifen |
3.70 | 19457130 |
MESH:D016135 |
Spinal Dysraphism |
|
Valproic Acid |
3.52 | 19490988 |
MESH:D013226 |
Status Epilepticus |
|
Valproic Acid |
4.19 | 12833885 |
MESH:D013274 |
Stomach Neoplasms |
|
Benzo(a)pyrene |
1.55 | 2093021 20155912 |
MESH:D019851 |
Thrombophilia |
|
Ethinyl Estradiol |
3.31 | 11994571 |
MESH:D013927 |
Thrombosis |
|
Ethinyl Estradiol |
2.87 | 15669648 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
3.56 | 12697716 |
MESH:D014178 |
Translocation, Genetic |
|
Valproic Acid |
4.89 | 17262798 |
MESH:D020194 |
Unverricht-Lundborg Syndrome |
|
Valproic Acid |
4.18 | 3119515 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Benzo(a)pyrene |
4.53 | 17053015 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Tamoxifen |
4.53 | 16712894 8653321 17572228 |
MESH:D014564 |
Urogenital Abnormalities |
|
Valproic Acid |
4.31 | 8888407 |
MESH:D014594 |
Uterine Neoplasms |
|
Ethinyl Estradiol |
2.98 | 14692618 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
3.64 | 1336536 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.25 | 12125929 |
MESH:D020246 |
Venous Thrombosis |
|
Ethinyl Estradiol |
3.24 | 14671159 15869587 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
3.90 | 15886252 |
MESH:D015430 |
Weight Gain |
|
Dietary Fats |
3.45 | 16723640 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
4.09 | 17120751 |